Stanford University
Showing 27,401-27,500 of 34,432 Results
-
Hiroyuki Shimada
Professor of Pathology and, by courtesy, of Pediatrics
BioHiroyuki Shimada, MD, PhD, FRCPA (Hon), is Professor of Pathology and of Pediatrics at the Stanford University Medical Center. He was born in Tokyo, Japan, and completed MD (1973) and PhD (1982) at the Yokohama City University School of Medicine, Yokohama, Japan, and also completed his pathology training at the Children's Hospital (now the Nationwide Children’s Hospital) and the Ohio State University, Columbus, Ohio, USA (1988). Before moving to the Stanford University in 2019, he was Professor of Pathology (Clinical Scholar) at the University of Southern California Keck School of Medicine and working at the Children’s Hospital Los Angeles.
Dr. Shimada was Chair of the International Neuroblastoma Pathology Committee (1999-2017) and the founder of the International Neuroblastoma Pathology Classification (INPC). As Director of the COG (Children’s Oncology Group) Neuroblastoma Pathology Reference Laboratory (since 2001), he has been actively reviewing pathology samples of ~700 neuroblastoma cases per year from United States, Canada, Australia, and New Zealand. Pathology review results according to the INPC have been providing critical information for patient stratification and protocol assignment in the COG international neuroblastoma clinical trials. -
Andrew Young Shin
Clinical Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsSURF PROGRAM
The SURF program is an innovative collaboration between LPCH, Stanford University Hospital and the Stanford School of Engineering. The program has focused on improving quality and safety of patient care, improving hospital operations and promoting clinical effectiveness utilizing contemporary technologies such as machine learning, mathematical optimization, simulation and a variety of statistical, probabilistic and computational tools. The program has 2 independent funding mechanism to primarily improve patient care/hospital operations and improve academics for faculty within the department of Pediatrics at LPCH.
https://surf.stanford.edu/
CLINICAL EFFECTIVENESS
The Clinical Effectiveness (CE) Program is a funded program that aims to understand and improve unnecessary variation in healthcare delivery in order to optimize quality of care and reduce wasteful expenditures. The CE program has developed innovative programs such as Target Based Care, an award-winning intervention to reduce variation in hospital length of stay and currently a multi-center trial involving more than 20 hospitals in North America. In 2016, the CE program included the first CE fellowship program in a pediatric training program with 3 cycles of graduates. The CE program is supported by LPCH and a philanthropic gift by Susan Choe and Thomas Tobiason. -
Chungheon Shin
Research Engineer, Civil and Environmental Engineering
BioChungheon Shin is the Research Director of the Codiga Resource Recovery Center at Stanford University. His research advances sustainable water and environmental technologies through process intensification, environmental biotechnology, and resource recovery. By integrating biological and physicochemical processes with mechanistic and data-driven computational models, he develops engineering solutions that recover clean water, energy, and valuable resources. His work spans multiple scales, from fundamental reaction kinetics to pilot- and demonstration-scale systems, with a strong emphasis on translating research into real-world applications.
His current research focuses on three complementary areas: process intensification, resource recovery, and digital optimization of water infrastructure. He has led the development of the Staged Anaerobic Fluidized-bed Membrane Bioreactor (SAF-MBR), an energy-positive wastewater treatment technology that has advanced to demonstration scale, and is developing pilot-scale methane-to-protein technologies that convert waste methane into sustainable protein through efficient gas transfer and environmental biotechnology. His research also integrates mechanistic understanding with data-driven modeling to optimize biological treatment processes and accelerate the deployment of next-generation water technologies.
Dr. Shin received his Ph.D. in Environmental Engineering from Inha University in South Korea, where he developed the SAF-MBR under the supervision of Professor Jaehoe Bae and Professor Perry L. McCarty. He subsequently joined the Department of Civil and Environmental Engineering at Stanford University as a postdoctoral scholar under Professor Craig S. Criddle, where he expanded his research in environmental biotechnology, process intensification, and sustainable water infrastructure. -
Dongjae Shin
Postdoctoral Scholar, Photon Science, SLAC
BioMy current research focuses on the design of catalytic materials. My approaches to this topic include:
(1) First-principles calculation: using density functional theory (DFT), I have studied atomistic phenomena on catalytic surfaces with the purpose of developing materials with improved catalytic capability under the philosophy of rational design and high-throughput screening.
(2) AI-accelerated first-principles calculation: I have applied AI algorithms, e.g., evolutionary algorithm, Bayesian optimization, to the acceleration of computationally costly processes, enabling exploration of larger catalytic design space.
(3) AI-steered adaptive experimentation: I have applied active learning methods, e.g., uncertainty-based sampling, Bayesian optimization, to construct proxies of whole landscape of catalytic performance, or to perform multi-objective optimization. This is the brain of self-driving laboratory (SDL).
Applications include heterogeneous catalysis for exhaust emission control, hydrogen production, utilization of emission gas to realize carbon neutralization, and discovery of battery materials. -
Gi-Wook Shin
William J. Perry Professor, Senior Fellow at the Freeman Spogli Institute for International Studies and Professor, by courtesy, of East Asian Languages and Cultures
Current Research and Scholarly InterestsKorean democratization; Korean nationalism; U.S.-Korea relations; North Korean politics; reconciliation and cooperation in Northeast Asia; global talent; multiculturalism; inter-Korean relations
-
Rizwan Hassan Shinwari
Visiting Instructor, Neurosurgery
BioRizwan Hassan Shinwari is a Visiting Instructor in the Department of Neurosurgery at Stanford University. His research focuses on the clinical outcomes and adverse effects associated with stereotactic radiosurgery, with the goal of optimizing patient care and advancing neurosurgical precision.
Dr. Shinwari earned his medical degree from Khyber Medical College and brings a strong background in clinical medicine and surgical sciences. His academic and professional interests lie at the intersection of neurosurgery, radiological innovation, and patient-centered outcomes research. He aspires to further his training and career as a neurosurgeon in the United States. -
Josh Shiode
Managing Director, KIPAC
BioJosh Shiode is Managing Director of the Kavli Institute for Particle Astrophysics and Cosmology (KIPAC), a joint institute of Stanford University and the SLAC National Laboratory. Prior to joining KIPAC, Josh served as Senior Advisor and Chief of Staff in the U.S. Department of Energy Office of Science, under the leadership of then Director Asmeret Asefaw Berhe. Josh received his PhD in astrophysics from UC Berkeley in 2013, and subsequently worked in a variety of science and technology policy roles in Washington, DC, including with the American Association for the Advancement of Science and the Pacific Northwest National Laboratory.
-
Parveen Shiraz, MD
Instructor, Medicine - Blood & Marrow Transplantation
Current Research and Scholarly InterestsI am a physician-scientist in the Division of Blood and Marrow Transplantation-Cell Therapy (BMT-CT) at Stanford University. The focus of my laboratory research is the exploration of safe and more accessible forms of cell therapy for myeloid malignancies. We are studying multi-antigen targeting antibodies and engineered Natural Killer cells for myeloid malignancies.
-
Siddu Shivanagoudra
Postdoctoral Scholar, Gastroenterology
BioSiddu Shivanagoudra is a postdoctoral scholar in the Spencer Lab investigating how gut microbiota-derived metabolites modulate intestinal immune signaling and barrier function. He holds an MS in Horticultural Sciences and a PhD in Biomedical Engineering from Texas A&M University. His work spans tryptophan metabolite biology, AHR/GPR35 signaling, and defined bacterial consortia, integrating cellular, transcriptomic, and metabolomic approaches. Siddu aims to translate these mechanistic insights into microbiome-targeted therapeutic strategies for inflammatory gut diseases.
-
Judith Shizuru
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsTransplantation of defined populations of allogeneic hematopoietic cells. Specifically, the way in which hematopoietic cell grafts alter antigen specific immune responses to allo-, auto- and viral antigens. The cellular and molecular basis of resistance to engraftment of allogeneic hematopoietic stem cells.
-
Eugene Shkolyar, MD
Clinical Assistant Professor, Urology
BioEugene Shkolyar, MD is a urologic oncologist who specializes in treating patients with bladder, prostate, kidney, and testis cancers. He is a clinical assistant professor in the Department of Urology at the Stanford School of Medicine.
Dr. Shkolyar has expertise in open, endoscopic, and robotic surgery and in caring for patients with complex urologic oncology needs. Dr. Shkolyar is actively engaged in translational research, with a particular interest in integrating artificial intelligence into bladder cancer treatment and the development of novel biomarkers for cancer detection. His commitment to continual innovation ensures that his patients have access to the latest and most effective treatment options.
Dr. Shkolyar was born in Kyiv, Ukraine, and raised in New York. He attended Cornell University for his undergraduate education and went on to UCLA for medical school. Following medical school, Dr. Shkolyar completed a residency in urology at Stanford, where he developed his interest in urologic oncology, translational bladder cancer research and teaching. He went on to complete a two-year fellowship in urologic oncology at Stanford School of Medicine gaining additional skills in management of complex urologic cancers. Dr. Shkolyar is the recipient of numerous honors and awards, including membership in the Alpha Omega Alpha medical honors society and a research scholar award from the Urology Care Foundation. In addition, he has authored and co-authored numerous publications in urology, artificial intelligence, and device development.
Dr. Shkolyar is a member of the Society of Urologic Oncology, the American Society of Clinical Oncology, the American Urological Association, and the European Association of Urology. -
Yoav Shoham
Professor of Computer Science, Emeritus
BioYoav Shoham is professor emeritus of computer science at Stanford University. A leading AI expert, Prof. Shoham is Fellow of AAAI, ACM and the Game Theory Society. Among his awards are the IJCAI Research Excellence Award, the AAAI/ACM Allen Newell Award, and the ACM/SIGAI Autonomous Agents Research Award. His online Game Theory course has been watched by close to a million people. Prof. Shoham has founded several AI companies, including TradingDynamics (acquired by Ariba), Katango and Timeful (both acquired by Google), and AI21 Labs. Prof. Shoham also chairs the AI Index initiative (www.AIindex.org), which tracks global AI activity and progress, and WeCode (www.wecode.org.il), a nonprofit initiative to train high-quality programmers from disadvantaged populations.
-
William Shomali
Clinical Assistant Professor, Medicine - Hematology
BioDr. Shomali is a clinical assistant professor of Hematology at Stanford University School of Medicine. He is board certified in hematology & medical oncology.
Dr. Shomali specializes in the treatment of blood cancers such as myeloproliferative neoplasms and myelodysplastic syndromes. He aims to provide compassionate, personalized, and evidence-based care to each patient.
Dr. Shomali received his medical degree from the University of Jordan, followed by a postdoctoral fellowship at MD Anderson Cancer Center where he studied infections in cancer patients and the role of biomarkers in defining tumor fever. He completed his residency training in Internal Medicine at the Cleveland Clinic Foundation where he served as a Chief Medical Resident. He then joined Stanford University for his combined Hematology & Oncology fellowship training.
Dr. Shomali’s research interests include the study of novel agents in myeloproliferative neoplasms and myelodysplastic syndromes. He developed investigator-initiated clinical trials for patients with eosinophilic neoplasms and advanced myelofibrosis. In addition, he co-authored several papers and book chapters discussing the care of patients with cancer. His work has been presented in national meetings and published in peer reviewed journals including Blood, American Journal of Hematology, British Journal of Hematology, Leukemia & Lymphoma, and Cancer.
Among his honors, Dr. Shomali received the Cleveland Clinic Excellence in Teaching Award and was named to the Alpha Omega Alpha Medical Honor Society. He has received a Young Investigator Award from the Conquer Cancer Foundation, an NIH Institutional National Research Service Award, and a Stanford Cancer Institute Fellowship Award.
Dr. Shomali is a member of the American Society of Hematology and the American Society of Clinical Oncology. -
Mahasish Shome
Postdoctoral Scholar, Genetics
BioMy research interest revolves around understanding the underlying mechanism of disease progression. I utilize multi-omics profiling to identify biomarkers relevant to the disease. I study autoantibodies, metabolomics and proteomics to decipher the connection of disease with biomarkers. For studying these, I use protein microarrays and mass spectrometry. Connecting various omics provide a holistic overview of the disease profile and can help in early diagnosis, understanding disease state and drug/vaccine effectiveness.
-
Jade Shorter, MD, MSHP
Clinical Associate Professor, Obstetrics & Gynecology
BioJade M. Shorter, MD, MSHP, is a Clinical Associate Professor of Obstetrics and Gynecology and Complex Family Planning at Stanford University School of Medicine. She serves as the Medical Director of Ambulatory Gynecology, Associate Division Director of Gynecology and Gynecologic Specialties, and Director of Stanford's Early Pregnancy Clinic. Dr. Shorter specializes in early pregnancy care, miscarriage management, pregnancy of unknown location, ectopic pregnancy, contraception, and office-based ultrasound. She is committed to providing compassionate, evidence-based care that supports patients through complex reproductive health decisions and periods of uncertainty.
An internationally recognized expert in early pregnancy care and pregnancy loss, Dr. Shorter co-chaired the Early Pregnancy Assessment Clinics Special Interest Group for the Society of Family Planning for five years and has mentored physicians and junior faculty across the United States in developing Early Pregnancy Assessment Clinics at their own institutions. Her scholarly work focuses on early pregnancy complications, reproductive health equity, and patient-centered approaches to care, and she has been invited to present her work at national and international conferences. Dr. Shorter's work is dedicated to improving and expanding access to high-quality early pregnancy care and advancing patient-centered models that improve outcomes and experiences for patients with early pregnancy complications. -
Linda M. Dairiki Shortliffe
Stanley McCormick Memorial Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsThe timing for intervention in obstruction in the infant and child is poorly understood.Our group has been interested in trying to define the risks that may be involved in obstructive and infectious uropathies and discovering early signs of damage to the urinary tract and kidney. We have explored ways of imaging the urinary tract using nonionizing radiation (US, MRI). We have studied the relationships of sex steroid hormones, pregnancy, reflux, urinary tract infection and urinary tract function.
-
Benjamin LZ Shou
Resident in Cardiothoracic Surgery - Thoracic Surgery
BioBenjamin Shou is a resident in the integrated cardiothoracic surgery program. He attended medical school at Johns Hopkins and completed his undergraduate degree at University of California, Los Angeles, in Molecular, Cell, and Developmental Biology with a concentration in Computational Biology. His academic interests include adult cardiac surgery, imaging, and artificial intelligence in healthcare.
-
Talya Shragai
Staff, Biology
Special Initiatives Manager, Disease Ecology In A Changing World, ContingentBioTalya is the Research and Program Manager for the Disease Ecology in a Changing World program where she works on projects that improve both human health and the health of the environment.
She earned her PhD in Medical Entomology at Cornell University, studying how mosquitos adapt and behave in novel environments in Colombia, Puerto Rico, and New York. Following her PhD, Talya worked at the Centers for Disease Control and Prevention in the Global Emergency Public Health and Global Immunization programs. Her work at the CDC combined capacity building, operational research, and collaborating with Ministries of Health across Africa, Latin America, and Asia to improve outbreak response and vaccine coverage around the world.
Talya is passionate about research that provides innovative, practical solutions to improve health. -
Joseph Shrager
Professor of Cardiothoracic Surgery
On Leave from 2026-08-31 To 2027-01-17Current Research and Scholarly InterestsIn clinical research, Dr. Shrager studies outcomes in several areas within Thoracic Surgery including: parenchyma-sparing operations and minimally invasive resections for lung cancer, subsolid lung cancers, thymectomy for myasthenia gravis and thymoma, diaphragm plication, and treatment of emphysema.
Dr. Shrager's lab is focused on the impact of disease states upon the diaphragm. His group published the seminal paper (NEJM) describing diaphragm atrophy assoc'd with mechanical ventilation. -
Prisha Shroff
Undergraduate, Vice Provost for Undergraduate Education
Biostanford.edu/~prisha
